Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg Open5 Apr 2025

Tumor burden score improves survival prediction in liver cancer.

A new classification for hepatocellular carcinoma enhances predictive accuracy for overall survival. In a study involving 1,766 patients, incorporating the tumor burden score (TBS) allowed reclassification into distinct categories, revealing improved five-year survival rates: the TBS-br model yielded rates of 70.8%, 58.3%, and 40.0% compared…

Ann Surg Open5 Apr 2025

SmartPAN demonstrates safe and effective intraoperative pancreatic leakage visualization

In a first-in-human trial, SmartPAN hydrogel proved safe and easy to use for visualizing intraoperative pancreatic leakage during partial resections. Out of 29 patients receiving SmartPAN, 10 demonstrated positive leakage responses, with postoperative pancreatic fistula (POPF) occurring in 7 patients. Surgeons rated the device highly…

Ann Surg Open4 Apr 2025

Machine learning effectively predicts optimal outcomes in liver surgery

A machine learning model successfully predicted textbook outcomes in liver surgery using preoperative data from over 2,000 patients. The top-performing xgboost model achieved an area under the curve of 0.73. Significant predictors included minimally invasive techniques and patient characteristics such as lower comorbidity scores. Furthermore,…

HPB & Spleen4 Apr 2025

Conditional survival predictions enhance outcomes for pancreatic cancer patients

A study on pancreatic ductal adenocarcinoma reveals that conditional survival analysis based on kallikrein-related peptidase 7 (klk7) expression can significantly improve prognostic assessments. Results show that 1-, 2-, and 3-year conditional survival rates increased from 50.4% to 91.2%, while overall survival rates dropped from 81.9%…

J Gastrointest Surg3 Apr 2025

Achievement of textbook outcomes improves survival in HPB surgery

A systematic review and meta-analysis evaluated textbook outcomes (TOs) in hepatopancreaticobiliary (HPB) surgery across 27 studies involving 517,304 patients. It revealed a median TO achievement rate of 62% for hepatic procedures, 54% for biliary, and lower rates for pancreatic and liver transplantation surgeries. Importantly, achieving…

Medicine (Baltimore)3 Apr 2025

Blood tests enhance differentiation between liver cancer types

A study involving 165 patients diagnosed with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) identified alpha-fetoprotein (AFP) and carbohydrate antigen 19-9 (CA19-9) as key tumor markers for accurate preoperative differentiation. Elevated white blood cell counts, neutrophil-to-lymphocyte ratios, and monocyte counts were linked to increased ICC…

World J Gastroenterol2 Apr 2025

Machine learning predicts surgical outcomes in cholangiocarcinoma patients

A machine learning model developed from 376 intrahepatic cholangiocarcinoma patients effectively predicts textbook outcomes. Key preoperative factors include Child-Pugh classification, ECOG score, hepatitis B status, and tumor size. The model achieved high accuracy during internal (AUC = 0.8825) and external validation (AUC = 0.8346). Survival…

HPB (Oxford)2 Apr 2025

Heterogeneity in outcome reporting impacts pancreatic surgery research

A systematic review of 156 studies on curative surgery for pancreatic adenocarcinoma reveals significant inconsistencies in outcome reporting. Researchers identified 2088 reported outcomes, resulting in 399 unique endpoints, with no single outcome universally reported. Alarmingly, 45% of these outcomes were undefined, indicating a lack of…

JHEP Rep2 Apr 2025

Soluble TREM2 predicts liver dysfunction after surgery.

Soluble TREM2 (strem2) levels in plasma effectively reflect liver fibrosis status and predict postoperative liver dysfunction in patients undergoing liver resection. In a cohort of 108 patients assessed before surgery and on postoperative days one and five, strem2 demonstrated sensitivity for early, asymptomatic chronic liver…